Advertisement

Apofore Corporation Company Profile

02:59 EDT 19th May 2013 | BioPortfolio

Apofore Corporation is a focused company founded by Patrick Tso, PhD and funded by HealthCare Ventures. ApoA-IV, the first therapeutic being prepared for clinical trials, has promising pre-clinical data supporting potential use in patients with Type 2 diabetes mellitus. For more information, please visit www.apofore.com.


News Articles [ 1 Associated News Articles listed on BioPortfolio]

Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New Potential Target for Type 2 Diabetes Therapeutics

Apofore Corporation today announced that its scientific founder at the University of Cincinnati, Patrick Tso, PhD, Professor in the Department of Pathology and Laboratory Medicine...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [ 1 Associated Companies listed on BioPortfolio]

Apofore Corporation

Apofore Corporation is a focused company founded by Patrick Tso, PhD and funded by HealthCare Ventures. ApoA-IV, the first therapeutic being prepared for clinical trials, has prom...

More Information about "Apofore Corporation" on BioPortfolio

We have published hundreds of Apofore Corporation news stories on BioPortfolio along with dozens of Apofore Corporation Clinical Trials and PubMed Articles about Apofore Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Apofore Corporation Companies in our database. You can also find out about relevant Apofore Corporation Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement